Replies to post #13047 on Sorrento Therapeutics Inc (SRNE)

[chxal]

Can I get some of what you're smoking???

Really, 68 Billion?

May 2020 SRNE had a one year target price of $25, a year and a half later it's at 2.59? On what basis do you get $68 Billion? The company has absolutely NO RECORD WHATSOEVER in getting products approved that generate revenue --NONE!

$68 Billion is a disservice to investors who have watched a company with seemingly great potential FAIL at EVERY TURN. And buying other companies has done NOTHING to improve the cash flow or revenue picture.

It's time for investors to invoke some shareholder activism, starting with getting on the next Proxy with a shareholder proposal to fire the CEO and sell the company. This guy CANNOT get it done, a failure in every regard.....

[dia76ca]

It is good to look at the Big Picture. Sorrento's portfolio is strong.
The wild card is approvals in MEXICO, BRAZIL, the UK or even by DARPA!
The Covid portfolio is needed. The testing portfolio is needed. The Cancer, Pain and SOFUSA technologies are all progressing! And news is coming soon!
All is well and all will be well.